Compounds > ketoconazole

ketoconazole and methamphetamine

ketoconazole has been researched along with methamphetamine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Anttila, M; Karnani, H; Nyman, L; Pelkonen, O; Salonen, JS; Taavitsainen, P1
Goeders, NE; Moffett, MC1
Grace, CE; Gudelsky, GA; Schaefer, TL; Vorhees, CV; Williams, MT1

Reviews

1 review(s) available for ketoconazole and methamphetamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for ketoconazole and methamphetamine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Selegiline metabolism and cytochrome P450 enzymes: in vitro study in human liver microsomes.
    Pharmacology & toxicology, 2000, Volume: 86, Issue:5

    Topics: Amphetamines; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Fluvoxamine; Humans; Ketoconazole; Methamphetamine; Microsomes, Liver; Mixed Function Oxygenases; Monoamine Oxidase Inhibitors; Selegiline; Theophylline

2000
CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats.
    Psychopharmacology, 2007, Volume: 190, Issue:2

    Topics: Amphetamine-Related Disorders; Animals; Corticotropin-Releasing Hormone; Cues; Dose-Response Relationship, Drug; Extinction, Psychological; Hypothalamo-Hypophyseal System; Infusions, Intravenous; Injections, Intraperitoneal; Injections, Intraventricular; Ketoconazole; Male; Methamphetamine; Motivation; Pituitary-Adrenal System; Premedication; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Self Administration

2007
Effects on plasma corticosterone levels and brain serotonin from interference with methamphetamine-induced corticosterone release in neonatal rats.
    Stress (Amsterdam, Netherlands), 2010, Volume: 13, Issue:6

    Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Animals, Newborn; Brain; Corticosterone; Dopamine; Female; Ketoconazole; Male; Methamphetamine; Metyrapone; Rats; Rats, Sprague-Dawley; Serotonin

2010